Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle
- PMID: 1313732
- PMCID: PMC1908673
- DOI: 10.1111/j.1476-5381.1992.tb14279.x
Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle
Abstract
1. The interaction of pinaverium bromide, a quaternary ammonium compound, with binding sites for (L-type) calcium channel blockers was investigated in rat ileum smooth muscle. 2. Pinaverium inhibited [3H]-(+)-PN200-110 ([3H]-(+)-isradipine) specific binding to tissue homogenates incompletely (Ki 0.38 microM; maximal inhibition 80%). In contrast, binding to single cell preparations (obtained by collagenase treatment) and to saponin-treated homogenates was completely inhibited. These data are compatible with the view that, in untreated homogenates, 20% of [3H]-(+)-isradipine binding sites are not accessible to pinaverium because it is associated with sealed inside-out vesicles. 3. Pinaverium bromide increased the apparent KD of [3H]-(+)-isradipine binding to saponin-treated homogenates but did not significantly affect the Bmax value. Moreover, the dissociation rate constant of [3H]-(+)-isradipine binding was not changed by pinaverium. These data suggest that pinaverium interacts with the dihydropyridine binding site in a competitive manner. However, in contrast to uncharged dihydropyridine calcium antagonists, pinaverium inhibited, rather than stimulated, [3H]-diltiazem binding to rat brain membranes (at 30-37 degrees C). 4. Although Bmax values of [3H]-(+)-isradipine were similar in homogenates prepared from tissue and cells (collagenase-treated), the KD value was significantly higher in cell homogenates (166 vs 95 pM). Similarly, the Ki value of pinaverium was higher in cell preparations than in tissue homogenates (0.77 vs 0.38 microM). Thus, collagenase can significantly modify the dihydropyridine recognition site.5. The competitive interaction of pinaverium, a permanently charged drug, with [3H]-(+)-isradipine bound to intact cells and its absence of interaction with [3H]-(+)-isradipine bound to sealed inside-out vesicles imply that the dihydropyridine receptor lies near the external surface of the plasma membrane.
Similar articles
-
Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.Br J Pharmacol. 1993 May;109(1):100-6. doi: 10.1111/j.1476-5381.1993.tb13537.x. Br J Pharmacol. 1993. PMID: 8495233 Free PMC article.
-
Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.Eur J Pharmacol. 1992 Apr 22;214(2-3):127-32. doi: 10.1016/0014-2999(92)90109-h. Eur J Pharmacol. 1992. PMID: 1325351
-
Binding sites for 1,4-dihydropyridine Ca(2+)-channel modulators in rat intestinal smooth muscle.Naunyn Schmiedebergs Arch Pharmacol. 1991 Dec;344(6):698-705. doi: 10.1007/BF00174754. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1837846
-
Action of pinaverium bromide, a calcium-antagonist, on gastrointestinal motility disorders.Gen Pharmacol. 1990;21(6):821-5. doi: 10.1016/0306-3623(90)90439-s. Gen Pharmacol. 1990. PMID: 2177709 Review.
-
Quaternary ammonium derivatives as spasmolytics for irritable bowel syndrome.Curr Pharm Des. 2004;10(28):3561-8. doi: 10.2174/1381612043382972. Curr Pharm Des. 2004. PMID: 15579053 Review.
Cited by
-
Brain regulation of gastric dysfunction induced by stress.Nat Metab. 2023 Sep;5(9):1494-1505. doi: 10.1038/s42255-023-00866-z. Epub 2023 Aug 17. Nat Metab. 2023. PMID: 37592008
-
Otilonium: a potent blocker of neuronal nicotinic ACh receptors in bovine chromaffin cells.Br J Pharmacol. 1996 Feb;117(3):463-470. doi: 10.1111/j.1476-5381.1996.tb15213.x. Br J Pharmacol. 1996. PMID: 8821535 Free PMC article.
-
Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial.J Clin Gastroenterol. 2020 Apr;54(4):e30-e39. doi: 10.1097/MCG.0000000000001242. J Clin Gastroenterol. 2020. PMID: 31385885 Free PMC article. Clinical Trial.
-
Sphincter of Oddi dysfunction: is there a role for medical therapy?Curr Gastroenterol Rep. 2002 Apr;4(2):172-6. doi: 10.1007/s11894-002-0056-5. Curr Gastroenterol Rep. 2002. PMID: 11900684 Review.
-
Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.Br J Pharmacol. 1993 May;109(1):100-6. doi: 10.1111/j.1476-5381.1993.tb13537.x. Br J Pharmacol. 1993. PMID: 8495233 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources